Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases
US-2020230138-A1 · Jul 23, 2020 · US
This page is not indexed by search engines while we improve data quality.
Kastelein John patents
Kastelein John is listed as an inventor on 3 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kastelein John |
| Total patents | 3 |
| First publication | Jun 29, 2017 |
| Latest publication | Jul 23, 2020 |
Notable patents
Publications ranked by popularity score, then publication date.
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
US-10653692-B2 · May 19, 2020 · US
Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases
US-2017182048-A1 · Jun 29, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dezima Pharma B V | 3 |
| Mitsubishi Tanabe Pharma Corp | 3 |
| Dezima Pharma Bv | 1 |
| Amgen Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/06 | 3 |
| A61P43/00 | 3 |
| A61K9/0053 | 3 |
| A61K9/20 | 3 |
| A61K31/4725 | 3 |